Literature DB >> 19255449

Functional basis of protection against age-related macular degeneration conferred by a common polymorphism in complement factor B.

Tamara Montes1, Agustín Tortajada, B Paul Morgan, Santiago Rodríguez de Córdoba, Claire L Harris.   

Abstract

Mutations and polymorphisms in complement genes have been linked with numerous rare and prevalent disorders, implicating dysregulation of complement in pathogenesis. The 3 common alleles of factor B (fB) encode Arg (fB(32R)), Gln (fB(32Q)), or Trp (fB(32W)) at position 32 in the Ba domain. The fB(32Q) allele is protective for age-related macular degeneration, the commonest cause of blindness in developed countries. Factor B variants were purified from plasma of homozygous individuals and were tested in hemolysis assays. The protective variant fB(32Q) had decreased activity compared with fB(32R). Biacore comparison revealed markedly different proenzyme formation; fB(32R) bound C3b with 4-fold higher affinity, and formation of activated convertase was enhanced. Binding and functional differences were confirmed with recombinant fB(32R) and fB(32Q); an intermediate affinity was revealed for fB(32W). To confirm contribution of Ba to binding, affinity of Ba for C3b was determined. Ba-fB(32R) had 3-fold higher affinity compared with Ba-fB(32Q). We demonstrate that the disease-protective effect of fB(32Q) is consequent on decreased potential to form convertase and amplify complement activation. Knowledge of the functional consequences of polymorphisms in complement activators and regulators will aid disease prediction and inform targeting of diagnostics and therapeutics.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19255449      PMCID: PMC2657369          DOI: 10.1073/pnas.0812584106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Factor B structure provides insights into activation of the central protease of the complement system.

Authors:  Fin J Milder; Lucio Gomes; Arie Schouten; Bert J C Janssen; Eric G Huizinga; Roland A Romijn; Wieger Hemrika; Anja Roos; Mohamed R Daha; Piet Gros
Journal:  Nat Struct Mol Biol       Date:  2007-02-25       Impact factor: 15.369

2.  Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration.

Authors:  Julian Maller; Sarah George; Shaun Purcell; Jes Fagerness; David Altshuler; Mark J Daly; Johanna M Seddon
Journal:  Nat Genet       Date:  2006-08-27       Impact factor: 38.330

3.  Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome.

Authors:  Elena Goicoechea de Jorge; Claire L Harris; Jorge Esparza-Gordillo; Luis Carreras; Elena Aller Arranz; Cynthia Abarrategui Garrido; Margarita López-Trascasa; Pilar Sánchez-Corral; B Paul Morgan; Santiago Rodríguez de Córdoba
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-20       Impact factor: 11.205

4.  Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration.

Authors:  Kylee L Spencer; Michael A Hauser; Lana M Olson; Silke Schmidt; William K Scott; Paul Gallins; Anita Agarwal; Eric A Postel; Margaret A Pericak-Vance; Jonathan L Haines
Journal:  Hum Mol Genet       Date:  2007-06-18       Impact factor: 6.150

5.  Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration.

Authors:  Bert Gold; Joanna E Merriam; Jana Zernant; Lisa S Hancox; Andrew J Taiber; Karen Gehrs; Kevin Cramer; Julia Neel; Julie Bergeron; Gaetano R Barile; R Theodore Smith; Gregory S Hageman; Michael Dean; Rando Allikmets
Journal:  Nat Genet       Date:  2006-03-05       Impact factor: 38.330

6.  Oxidative damage-induced inflammation initiates age-related macular degeneration.

Authors:  Joe G Hollyfield; Vera L Bonilha; Mary E Rayborn; Xiaoping Yang; Karen G Shadrach; Liang Lu; Rafael L Ufret; Robert G Salomon; Victor L Perez
Journal:  Nat Med       Date:  2008-01-27       Impact factor: 53.440

7.  Estimation of systemic complement C3 activity in age-related macular degeneration.

Authors:  Sobha Sivaprasad; Temi Adewoyin; Tracey A Bailey; Sam S Dandekar; Sharon Jenkins; Andrew R Webster; Ngaihang Victor Chong
Journal:  Arch Ophthalmol       Date:  2007-04

8.  Deletion of CFHR3 and CFHR1 genes in age-related macular degeneration.

Authors:  Kylee L Spencer; Michael A Hauser; Lana M Olson; Silke Schmidt; William K Scott; Paul Gallins; Anita Agarwal; Eric A Postel; Margaret A Pericak-Vance; Jonathan L Haines
Journal:  Hum Mol Genet       Date:  2007-12-15       Impact factor: 6.150

9.  Complement C3 variant and the risk of age-related macular degeneration.

Authors:  John R W Yates; Tiina Sepp; Baljinder K Matharu; Jane C Khan; Deborah A Thurlby; Humma Shahid; David G Clayton; Caroline Hayward; Joanne Morgan; Alan F Wright; Ana Maria Armbrecht; Baljean Dhillon; Ian J Deary; Elizabeth Redmond; Alan C Bird; Anthony T Moore
Journal:  N Engl J Med       Date:  2007-07-18       Impact factor: 91.245

10.  C2 and CFB genes in age-related maculopathy and joint action with CFH and LOC387715 genes.

Authors:  Johanna Jakobsdottir; Yvette P Conley; Daniel E Weeks; Robert E Ferrell; Michael B Gorin
Journal:  PLoS One       Date:  2008-05-21       Impact factor: 3.240

View more
  38 in total

Review 1.  Animal models of age related macular degeneration.

Authors:  Mark E Pennesi; Martha Neuringer; Robert J Courtney
Journal:  Mol Aspects Med       Date:  2012-06-15

Review 2.  C3 glomerulopathy: a new classification.

Authors:  Fadi Fakhouri; Véronique Frémeaux-Bacchi; Laure-Hélène Noël; H Terence Cook; Matthew C Pickering
Journal:  Nat Rev Nephrol       Date:  2010-07-06       Impact factor: 28.314

Review 3.  The molecular genetic basis of age-related macular degeneration: an overview.

Authors:  Saritha Katta; Inderjeet Kaur; Subhabrata Chakrabarti
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

4.  Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk.

Authors:  Meike Heurich; Ruben Martínez-Barricarte; Nigel J Francis; Dawn L Roberts; Santiago Rodríguez de Córdoba; B Paul Morgan; Claire L Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-09       Impact factor: 11.205

5.  Genome-wide association study identifies two susceptibility loci for exudative age-related macular degeneration in the Japanese population.

Authors:  Satoshi Arakawa; Atsushi Takahashi; Kyota Ashikawa; Naoya Hosono; Tomomi Aoi; Miho Yasuda; Yuji Oshima; Shigeo Yoshida; Hiroshi Enaida; Takashi Tsuchihashi; Keisuke Mori; Shigeru Honda; Akira Negi; Akira Arakawa; Kazuaki Kadonosono; Yutaka Kiyohara; Naoyuki Kamatani; Yusuke Nakamura; Tatsuro Ishibashi; Michiaki Kubo
Journal:  Nat Genet       Date:  2011-09-11       Impact factor: 38.330

Review 6.  Dense deposit disease.

Authors:  Richard J H Smith; Claire L Harris; Matthew C Pickering
Journal:  Mol Immunol       Date:  2011-05-24       Impact factor: 4.407

7.  Gene expression changes in aging retinal microglia: relationship to microglial support functions and regulation of activation.

Authors:  Wenxin Ma; Radu Cojocaru; Norimoto Gotoh; Linn Gieser; Rafael Villasmil; Tiziana Cogliati; Anand Swaroop; Wai T Wong
Journal:  Neurobiol Aging       Date:  2013-04-19       Impact factor: 4.673

8.  Genetic control of the alternative pathway of complement in humans and age-related macular degeneration.

Authors:  Laura A Hecker; Albert O Edwards; Euijung Ryu; Nirubol Tosakulwong; Keith H Baratz; William L Brown; Peter Charbel Issa; Hendrik P Scholl; Beatrix Pollok-Kopp; Katharina E Schmid-Kubista; Kent R Bailey; Martin Oppermann
Journal:  Hum Mol Genet       Date:  2010-01-01       Impact factor: 6.150

9.  The disease-protective complement factor H allotypic variant Ile62 shows increased binding affinity for C3b and enhanced cofactor activity.

Authors:  Agustín Tortajada; Tamara Montes; Rubén Martínez-Barricarte; B Paul Morgan; Claire L Harris; Santiago Rodríguez de Córdoba
Journal:  Hum Mol Genet       Date:  2009-06-23       Impact factor: 6.150

10.  Genetic variations in complement factors in patients with congenital thrombotic thrombocytopenic purpura with renal insufficiency.

Authors:  Xinping Fan; Johanna A Kremer Hovinga; Hiroko Shirotani-Ikejima; Yuka Eura; Hidenori Hirai; Shigenori Honda; Koichi Kokame; Magnus Mansouri Taleghani; Anne-Sophie von Krogh; Yoko Yoshida; Yoshihiro Fujimura; Bernhard Lämmle; Toshiyuki Miyata
Journal:  Int J Hematol       Date:  2016-02-01       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.